Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer
نویسندگان
چکیده
منابع مشابه
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.
Chemotherapy has produced unsatisfactory results in pancreas cancer and novel approaches, including treatment tailoring by pharmacogenetic analysis and new molecular-targeted drugs, are required. The scarcity of effective therapies may reflect the lack of knowledge about the influence of tumor-related molecular abnormalities on responsiveness to drugs. Advances in the understanding of pancreas ...
متن کاملPharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer.
In mammalian cells, the process of malignant transformation is characterized by the loss or down-regulation of tumor-suppressor genes and/or the mutation or overexpression of proto-oncogenes, whose products promote dysregulated proliferation of cells and extend their life span. Deregulation in intracellular transduction pathways generates mitogenic signals that promote abnormal cell growth and ...
متن کاملPharmacogenetics in pancreatic cancer.
Pancreatic cancer is an aggressive malignancy with a poor overall survival rate. Given advances in pharmacogenomics, numerous gene mutations have been identified that could be potential targets for drug development. Therefore, future research strategies may identify prognostic and predictive markers aiming to improve outcome by maximizing efficacy whilst lowering toxicity. In this commentary, w...
متن کاملpharmacogenetics and personalized medicine in pancreatic cancer
pancreatic cancer (pc) is a progressive, fatal disease with a high degree of malignancy. more than 40000 peoplediefrom this cancer annually in the united states. as a multifactorial condition, pc has a complex nature, and there are several genes and signalingpathwaysimplicated in pc pathogenesis and progression. there are diffèrent mutations in master genesincludingtumorsuppressors and oncogene...
متن کاملBiomarkers and Pharmacogenetics in Pancreatic Cancer
Author Title Stage of cancers Main findings #4022 McWilliams, et al. [3] Genome-wide interaction study of gemcitabine treatment and genotype on survival in pancreatic cancer All stages Nine out of 550,000 SNPs found as potential predictive biomarkers for gemcitabine therapy. No SNPs-specific toxicities are noticed #e14657 de Albuquerque, et al. [9] Prognostic significance of multimarker circula...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Molecular Cancer Therapeutics
سال: 2006
ISSN: 1535-7163,1538-8514
DOI: 10.1158/1535-7163.mct-06-0004